Advertisements

Rexahn Pharmaceuticals Inc. (RNN) Stock Quote

Detailed Quote for Rexahn Pharmaceuticals Inc. (RNN)
$ 3.01   0.0288 (+0.97%) Volume: 147.1k 4:02 PM EDT Jun 22, 2017
After Hours:  $ 3.06   0.05 (+1.66%) Volume: 700 7:53 PM EDT Jun 22, 2017
Today 5d 1m 3m 1y more
Last Price
3.01
Change $
0.0288
Change %
0.97%
Tick
  
Bid
N/A
Bid Size
0
Ask
N/A
Ask Size
0
Open
3.00
High
3.10
Low
2.99
Prev Close
2.9812
Last Trade
4:02
Volume
147.1k
52 Wk Hi
7.0999999
52 Wk Low
1.26999998
Market Cap
85.58m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
28,430,304
EPS (TTM)
-1.10000002
PE Ratio
N/A
Exchange
NYSE American
News and Media for Rexahn Pharmaceuticals Inc. (RNN)
Sector News | Topic News
News for Rexahn Pharmaceuticals Inc. (RNN)
Wed, Jun 07, 2017
12:38 PM Midday Gainers / Losers - SeekingAlpha
11:36 AM Rexahn Pharma announces direct equity sale to institutional investors; shares slip 15% - SeekingAlpha
9:19 AM Premarket Losers as of 9:05 am - SeekingAlpha
8:50 AM Rexahn Announces $10 Million Registered Direct Offering - GlobeNewswire
Sun, Jun 04, 2017
9:00 AM Rexahn Pharmaceuticals Presents Preliminary Efficacy Data from the Ongoing Phase IIa Clinical Trial of RX-3117 in Metastatic Bladder Cancer at the American Society of Clinical Oncology (ASCO) 2017 Annual Meeting - GlobeNewswire
Tue, May 09, 2017
12:57 PM Midday Gainers / Losers - SeekingAlpha
Mon, May 08, 2017
9:01 AM Rexahn Pharmaceuticals to Present RX-3117 Clinical Data at the American Society of Clinical Oncology (ASCO) 2017 Annual Meeting - GlobeNewswire
Fri, May 05, 2017
9:00 AM Rexahn Effects 1-for-10 Reverse Stock Split - GlobeNewswire
Thu, May 04, 2017
9:01 AM Rexahn Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update - GlobeNewswire
Thu, Apr 13, 2017
9:00 AM Rexahn Announces 1-for-10 Reverse Stock Split - GlobeNewswire
Tue, Mar 28, 2017
9:41 AM BioDelivery Sciences International and Rexahn Pharmaceuticals See Share Values Rise Slightly - ACCESSWIRE
Thu, Mar 16, 2017
9:31 AM Trade Volume Can Speak a Lot About Momentum of a Stock - ACCESSWIRE
Mon, Feb 27, 2017
9:10 AM Rexahn Pharmaceuticals reports FY results - SeekingAlpha
9:01 AM Rexahn Pharmaceuticals Reports Full Year 2016 Financial Results and Provides Corporate Update - GlobeNewswire
Thu, Feb 23, 2017
9:00 AM Rexahn Pharmaceuticals Doses First Patient in a Phase IIa Trial of Supinoxin(TM) in Patients with Metastatic Triple Negative Breast Cancer - GlobeNewswire
Fri, Jan 20, 2017
9:00 AM Rexahn Pharmaceuticals Presents an Update of the Ongoing Phase IIa Clinical Trial of RX-3117 in Metastatic Pancreatic Cancer at the American Society of Clinical Oncology (ASCO) 2017 Gastrointestinal Cancers Symposium - GlobeNewswire
Tue, Jan 03, 2017
9:01 AM Rexahn Pharmaceuticals to Present at Biotech Showcase(TM) 2017 - GlobeNewswire
Mon, Nov 07, 2016
2:07 PM Rexahn Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update - GlobeNewswire
Mon, Oct 31, 2016
9:01 AM Rexahn Pharmaceuticals Receives a Notice of Allowance from the U.S. Patent and Trademark Office for a Patent Covering the Manufacturing of RX-3117 - A Cancer Cell Specific Anticancer Agent - GlobeNewswire
Wed, Oct 26, 2016
9:03 AM Rexahn Pharmaceuticals Receives U.S. Patent for RX-21101: A Novel Nano-Polymer Conjugate of Docetaxel for the Targeted Treatment of Solid Tumors - GlobeNewswire
More News for RNN >>

Tags for Rexahn Pharmaceuticals Inc.

Research stocks or mutual funds related to Rexahn Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to RNN. The keywords below have been associated to RNN by either user submission or electronic means.

Drugs Healthcare Common Stock Pharmaceutical Preparation Manufacturing (325412) Pharmaceutical Preparations (2834)